Literature DB >> 23673647

Clusterin and LRP2 are critical components of the hypothalamic feeding regulatory pathway.

So Young Gil1, Byung-Soo Youn, Kyunghee Byun, Hu Huang, Churl Namkoong, Pil-Geum Jang, Joo-Yong Lee, Young-Hwan Jo, Gil Myoung Kang, Hyun-Kyong Kim, Mi-Seon Shin, Claus U Pietrzik, Bonghee Lee, Young-Bum Kim, Min-Seon Kim.   

Abstract

Hypothalamic feeding circuits are essential for the maintenance of energy balance. There have been intensive efforts to discover new biological molecules involved in these pathways. Here we report that central administration of clusterin, also called apolipoprotein J, causes anorexia, weight loss and activation of hypothalamic signal transduction-activated transcript-3 in mice. In contrast, inhibition of hypothalamic clusterin action results in increased food intake and body weight, leading to adiposity. These effects are likely mediated through the mutual actions of the low-density lipoprotein receptor-related protein-2, a potential receptor for clusterin, and the long-form leptin receptor. In response to clusterin, the low-density lipoprotein receptor-related protein-2 binding to long-form leptin receptor is greatly enhanced in cultured neuronal cells. Furthermore, long-form leptin receptor deficiency or hypothalamic low-density lipoprotein receptor-related protein-2 suppression in mice leads to impaired hypothalamic clusterin signalling and actions. Our study identifies the hypothalamic clusterin-low-density lipoprotein receptor-related protein-2 axis as a novel anorexigenic signalling pathway that is tightly coupled with long-form leptin receptor-mediated signalling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23673647     DOI: 10.1038/ncomms2896

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  32 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Apolipoprotein D interacts with the long-form leptin receptor: a hypothalamic function in the control of energy homeostasis.

Authors:  Z Liu; G Q Chang; S F Leibowitz
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

Review 3.  Signal transduction and endocytosis: close encounters of many kinds.

Authors:  Alexander Sorkin; Mark Von Zastrow
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

4.  Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

Authors:  B V Zlokovic; C L Martel; E Matsubara; J G McComb; G Zheng; R T McCluskey; B Frangione; J Ghiso
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

5.  Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice.

Authors:  C Vaisse; J L Halaas; C M Horvath; J E Darnell; M Stoffel; J M Friedman
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

6.  Megalin mediates the transport of leptin across the blood-CSF barrier.

Authors:  Marcelo O Dietrich; Carlos Spuch; Dessire Antequera; Izaskun Rodal; Justo G de Yébenes; José Antonio Molina; Felix Bermejo; Eva Carro
Journal:  Neurobiol Aging       Date:  2007-02-26       Impact factor: 4.673

7.  The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330.

Authors:  M Z Kounnas; W S Argraves; D K Strickland
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

8.  Localization and molecular heterogeneity of sulfated glycoprotein-2 (clusterin) among ventral prostate, seminal vesicle, testis, and epididymis of rats.

Authors:  J A Sensibar; Y Qian; M D Griswold; S R Sylvester; C W Bardin; C Y Cheng; C Lee
Journal:  Biol Reprod       Date:  1993-08       Impact factor: 4.285

9.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

10.  Brain apolipoprotein E: an important regulator of food intake in rats.

Authors:  Ling Shen; Patrick Tso; Stephen C Woods; Deborah J Clegg; Kyna L Barber; Katherine Carey; Min Liu
Journal:  Diabetes       Date:  2008-06-16       Impact factor: 9.461

View more
  24 in total

Review 1.  Leptin signalling pathways in hypothalamic neurons.

Authors:  Obin Kwon; Ki Woo Kim; Min-Seon Kim
Journal:  Cell Mol Life Sci       Date:  2016-01-19       Impact factor: 9.261

2.  Reanalysis of parabiosis of obesity mutants in the age of leptin.

Authors:  Wenwen Zeng; Yi-Hsueh Lu; Jonah Lee; Jeffrey M Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

Review 3.  Hypothalamic redox balance and leptin signaling - Emerging role of selenoproteins.

Authors:  Ting Gong; Daniel J Torres; Marla J Berry; Matthew W Pitts
Journal:  Free Radic Biol Med       Date:  2018-03-05       Impact factor: 7.376

Review 4.  The ANKS1B gene and its associated phenotypes: focus on CNS drug response.

Authors:  Rabha M Younis; Rachel M Taylor; Patrick M Beardsley; Joseph L McClay
Journal:  Pharmacogenomics       Date:  2019-06       Impact factor: 2.533

5.  A next generation sequencing gene panel for use in the diagnosis of anorexia nervosa.

Authors:  Maria Rachele Ceccarini; Vincenza Precone; Elena Manara; Stefano Paolacci; Paolo Enrico Maltese; Valentina Benfatti; Kristjana Dhuli; Kevin Donato; Giulia Guerri; Giuseppe Marceddu; Pietro Chiurazzi; Laura Dalla Ragione; Tommaso Beccari; Matteo Bertelli
Journal:  Eat Weight Disord       Date:  2021-11-25       Impact factor: 4.652

Review 6.  The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.

Authors:  S Park; K W Mathis; I K Lee
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

7.  Clusterin/ApoJ enhances central leptin signaling through Lrp2-mediated endocytosis.

Authors:  Kyunghee Byun; So Young Gil; Churl Namkoong; Byung-Soo Youn; Hu Huang; Mi-Seon Shin; Gil Myoung Kang; Hyun-Kyong Kim; Bonghee Lee; Young-Bum Kim; Min-Seon Kim
Journal:  EMBO Rep       Date:  2014-05-12       Impact factor: 8.807

8.  Circulating ApoJ is closely associated with insulin resistance in human subjects.

Authors:  Ji A Seo; Min-Cheol Kang; Theodore P Ciaraldi; Sang Soo Kim; Kyong Soo Park; Charles Choe; Won Min Hwang; Dong Mee Lim; Olivia Farr; Christos Mantzoros; Robert R Henry; Young-Bum Kim
Journal:  Metabolism       Date:  2017-10-03       Impact factor: 8.694

9.  Mechanisms that minimize retinal impact of apolipoprotein E absence.

Authors:  Aicha Saadane; Alexey Petrov; Natalia Mast; Nicole El-Darzi; Tung Dao; Ahab Alnemri; Ying Song; Joshua L Dunaief; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2018-10-17       Impact factor: 5.922

10.  Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy.

Authors:  Donghong Cui; Yanmin Peng; Chengfang Zhang; Zezhi Li; Yousong Su; Yadan Qi; Mengjuan Xing; Jia Li; Grace E Kim; Kevin N Su; Jinjie Xu; Meiti Wang; Wenhua Ding; Marta Piecychna; Lin Leng; Michiru Hirasawa; Kaida Jiang; Lawrence Young; Yifeng Xu; Dake Qi; Richard Bucala
Journal:  J Clin Invest       Date:  2018-10-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.